Annexon, Inc. (ANNX) Stock Grade

About Annexon, Inc.'s fundamentals

Annexon is a biotechnology company with a market capitalization of $778.6 million that reported no year-over-year revenue growth and a net loss in its latest annual statement, resulting in a net margin of 0.0%. The company offers a minimal dividend yield of 0.2%, which is typical for early-stage biotech firms. Traditional profitability metrics like P/E ratio and return on equity are not meaningful given the company's current loss-making status, indicating it is in a development or pre-commercialization phase common in the biotechnology sector.